Evidex Alert Download
Evidex Alert: Analysis of Q1 2017 FDA Safety Signals
By Downloading this Evidex Alert you will access:
- An analysis of the 14 safety signals FDA commented on based on Q1 2017 FAERS data
- Disproportionality analysis using Advera Health's Evidex platform
- Contextual data and analysis that can not be found anywhere else
For full access to this free report, please complete the form on this page.
Please note: This is an independent analysis conducted by Advera Health, based upon data and insight generated by the analytical tools of Evidex and other pertinent information gathered at the time of publication. This analysis is not sponsored or influenced by any third party. The inclusion of a particular company, drug, adverse event, class or indication in this report is determined wholly by our quantitative signaling and analytic systems along with our qualitative analysis work.